1. Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations. Issue 1 (3rd December 2015) Authors: Suzawa, Ken; Toyooka, Shinichi; Sakaguchi, Masakiyo; Morita, Mizuki; Yamamoto, Hiromasa; Tomida, Shuta; Ohtsuka, Tomoaki; Watanabe, Mototsugu; Hashida, Shinsuke; Maki, Yuho; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro Journal: Cancer science Issue: Volume 107:Issue 1(2016) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Integrated fluorescent cytology with nano‐biologics in peritoneally disseminated gastric cancer. Issue 10 (23rd September 2018) Authors: Watanabe, Megumi; Kagawa, Shunsuke; Kuwada, Kazuya; Hashimoto, Yuuri; Shigeyasu, Kunitoshi; Ishida, Michihiro; Sakamoto, Shuichi; Ito, Atene; Kikuchi, Satoru; Kuroda, Shinji; Kishimoto, Hiroyuki; Tomida, Shuta; Yoshida, Ryuichi; Tazawa, Hiroshi; Urata, Yasuo; Fujiwara, Toshiyoshi Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer. Issue 10 (14th September 2018) Authors: Sato, Hiroki; Yamamoto, Hiromasa; Sakaguchi, Masakiyo; Shien, Kazuhiko; Tomida, Shuta; Shien, Tadahiko; Ikeda, Hirokuni; Hatono, Minami; Torigoe, Hidejiro; Namba, Kei; Yoshioka, Takahiro; Kurihara, Eisuke; Ogoshi, Yusuke; Takahashi, Yuta; Soh, Junichi; Toyooka, Shinichi Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions. Issue 10 (11th September 2018) Authors: Kato, Yuka; Ninomiya, Kiichiro; Ohashi, Kadoaki; Tomida, Shuta; Makimoto, Go; Watanabe, Hiromi; Kudo, Kenichiro; Matsumoto, Shingo; Umemura, Shigeki; Goto, Koichi; Ichihara, Eiki; Ninomiya, Takashi; Kubo, Toshio; Sato, Akiko; Hotta, Katsuyuki; Tabata, Masahiro; Toyooka, Shinichi; Maeda, Yoshinobu... Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers. Issue 3 (16th January 2020) Authors: Takeda, Tatsuaki; Yamamoto, Hiromasa; Suzawa, Ken; Tomida, Shuta; Miyauchi, Shunsaku; Araki, Kota; Nakata, Kentaro; Miura, Akihiro; Namba, Kei; Shien, Kazuhiko; Soh, Junichi; Shien, Tadahiko; Kitamura, Yoshihisa; Sendo, Toshiaki; Toyooka, Shinichi Journal: Cancer science Issue: Volume 111:Issue 3(2020) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oncogenic potential of human pluripotent stem cell‐derived lung organoids with HER2 overexpression. Issue 8 (7th July 2021) Authors: Miura, Akihiro; Yamada, Daisuke; Nakamura, Masahiro; Tomida, Shuta; Shimizu, Dai; Jiang, Yan; Takao, Tomoka; Yamamoto, Hiromasa; Suzawa, Ken; Shien, Kazuhiko; Yamane, Masaomi; Sakaguchi, Masakiyo; Toyooka, Shinichi; Takarada, Takeshi Journal: International journal of cancer Issue: Volume 149:Issue 8(2021) Page Start: 1593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical and immune profiling for cancer of unknown primary site. Issue 1 (13th September 2019) Authors: Haratani, Koji; Hayashi, Hidetoshi; Takahama, Takayuki; Nakamura, Yasushi; Tomida, Shuta; Yoshida, Takeshi; Chiba, Yasutaka; Sawada, Takahiro; Sakai, Kazuko; Fujita, Yoshihiko; Togashi, Yosuke; Tanizaki, Junko; Kawakami, Hisato; Ito, Akihiko; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation. Issue 7 (4th May 2021) Authors: Shi, Hanxiao; Niimi, Atsuko; Takeuchi, Toshiyuki; Shiogama, Kazuya; Mizutani, Yasuyoshi; Kajino, Taisuke; Inada, Kenichi; Hase, Tetsunari; Hatta, Takahiro; Shibata, Hirofumi; Fukui, Takayuki; Chen‐Yoshikawa, Toyofumi Fengshi; Nagano, Kazuki; Murate, Takashi; Kawamoto, Yoshiyuki; Tomida, Shuta; Ta... Journal: Cancer science Issue: Volume 112:Issue 7(2021) Page Start: 2770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations. Issue 5 (15th April 2018) Authors: Torigoe, Hidejiro; Shien, Kazuhiko; Takeda, Tatsuaki; Yoshioka, Takahiro; Namba, Kei; Sato, Hiroki; Suzawa, Ken; Yamamoto, Hiromasa; Soh, Junichi; Sakaguchi, Masakiyo; Tomida, Shuta; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi Journal: Cancer science Issue: Volume 109:Issue 5(2018) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinicopathological and genetic differences between low‐grade and high‐grade colorectal mucinous adenocarcinomas. Issue 24 (21st October 2015) Authors: Yoshioka, Yasumasa; Togashi, Yosuke; Chikugo, Takaaki; Kogita, Akihiro; Taguri, Masataka; Terashima, Masato; Mizukami, Takuro; Hayashi, Hidetoshi; Sakai, Kazuko; de Velasco, Marco A.; Tomida, Shuta; Fujita, Yoshihiko; Tokoro, Tadao; Ito, Akihiko; Okuno, Kiyotaka; Nishio, Kazuto Journal: Cancer Issue: Volume 121:Issue 24(2015) Page Start: 4359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗